L&G Pharma Breakthrough UCITS ETFBIGT

BIGT current price
GBX 8.06-0.62%

Capital at risk.

1W
+0.25%
1M
-2.77%
3M
+4.54%
6M
+6.05%
1Y
-0.62%
MAX
+11.48%
About L&G Pharma Breakthrough UCITS ETF
Base currency
info
$ USD
Trading Cyrrency
info
GBX
ISIN
info
IE00BF0H7608
Trading on
info
LSE
Ticker
info
BIGT
Fund manager
info
Legal & General
Key facts & metrics
BasicAdvanced
Fund size
info
£18.3M
income
info
Distributing
Expense Ratio
info
49.00%
Dividend Yield
info
1.04089
Valuation
Price to prospective earnings
info
14.71
Price to book
info
2.96
Price to sales
info
2.4
Price to cashflow
info
10.76
Price
52-week High
info
GBX 855.47
52-week Low
info
GBX 721.90
50-day moving average
info
GBX 817.73
200-day moving average
info
GBX 786.26
Technicals
YTD
info
1.86%
Year 1
info
2.82%
Year 3
info
5.43%
Year 5
info
2.79%
Year 10
info
0.00%
Volatility Year 1
info
17.30%
Volatility Year 3
info
14.88%
Expected Return Year 3
info
4.60%
Sharpe Ratio
info
0.54%
Growth
Long term projected earnings
info
19.97%
Historical earnings
info
8.61%
Sales
info
5.54%
Cash flow
info
9.59%
Book value
info
6.52%
Sector breakdown
sector logo

Healthcare

% 96,90

sector logo

Materials

% 3,10

Regional breakdown

North America

% 53,65

Asia

% 25,34

Europe

% 15,78

Australia

% 2,63

UK

% 2,60

Top 10 Holdings
provider logo
Innocare Pharma Ltd

3.53%

provider logo
BeiGene

3.26%

provider logo
LG Chemicals

3.14%

provider logo
Pharma Mar SAU

3.09%

provider logo
Alnylam Pharmaceuticals

3.02%

provider logo
Xeris Pharmaceuticals Inc

2.96%

provider logo
Bristol-Myers Squibb

2.94%

provider logo
Nippon Shinyaku

2.89%

provider logo
Chugai Pharmaceutical Co. Ltd.

2.88%

provider logo
United Therapeutics

2.8%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

What is the name of BIGT?
Collapse

The name of BIGT is L&G Pharma Breakthrough UCITS ETF.

What is the ticker of L&G Pharma Breakthrough UCITS ETF?
Collapse

The primary ticker of L&G Pharma Breakthrough UCITS ETF is BIGT.

What is the ISIN of L&G Pharma Breakthrough UCITS ETF?
Collapse

The ISIN of L&G Pharma Breakthrough UCITS ETF is IE00BF0H7608.

What are the costs of L&G Pharma Breakthrough UCITS ETF
Collapse

The total expense ratio (TER) of L&G Pharma Breakthrough UCITS ETF amounts to 49.00% p.a. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately.

Does L&G Pharma Breakthrough UCITS ETF pay dividends?
Collapse

Yes, L&G Pharma Breakthrough UCITS ETF does pay dividends.

What currency is L&G Pharma Breakthrough UCITS ETF traded in?
Collapse

L&G Pharma Breakthrough UCITS ETF is traded in GBX.

Is L&G Pharma Breakthrough UCITS ETF an accumulating or distributing ETF?
Collapse

L&G Pharma Breakthrough UCITS ETF is distributing.

Who is the fund manager of “L&G Pharma Breakthrough UCITS ETF?
Collapse

The fund manager of L&G Pharma Breakthrough UCITS ETF is Legal & General.

What is the fund size of L&G Pharma Breakthrough UCITS ETF?
Collapse

The fund size of L&G Pharma Breakthrough UCITS ETF is £18.3M.

Mini Background Pattern
Stars Pattern
Astronaut flamingo

Invest your money to its potential

When you invest your capital is at risk.